Annual Drug Patent Expirations for QUTENZA
Qutenza is a drug marketed by Averitas and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
Drug patent litigation for QUTENZA.
This drug has sixty-nine patent family members in twenty-nine countries.
The generic ingredient in QUTENZA is capsaicin. One supplier is listed for this compound. Additional details are available on the capsaicin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
